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Abstract
Background: BK channels are usually activated by membrane depolarization and cytoplasmic Ca
2+. Especially,the activity of
BK channel (a+b4) can be modulated by martentoxin, a 37 residues peptide, with Ca
2+-dependent manner. gBK channel
(glioma BK channel) and BK channel (a+b1) possessed higher Ca
2+ sensitivity than other known BK channel subtypes.
Methodology and Principal Findings: The present study investigated the modulatory characteristics of martentoxin on
these two BK channel subtypes by electrophysiological recordings, cell proliferation and Ca
2+ imaging. In the presence of
cytoplasmic Ca
2+, martentoxin could enhance the activities of both gBK and BK channel (a+b1) subtypes in dose-dependent
manner with EC50 of 46.7 nM and 495 nM respectively, while not shift the steady-state activation of these channels. The
enhancement ratio of martentoxin on gBK and BK channel (a+b1) was unrelated to the quantitive change of cytoplasmic
Ca
2+ concentrations though the interaction between martentoxin and BK channel (a+b1) was accelerated under higher
cytoplasmic Ca
2+. The selective BK pore blocker iberiotoxin could fully abolish the enhancement of these two BK subtypes
induced by martentoxin, suggesting that the auxiliary b subunit might contribute to the docking for martentoxin. However,
in the absence of cytoplasmic Ca
2+, the activity of gBK channel would be surprisingly inhibited by martentoxin while BK
channel (a+b1) couldn’t be affected by the toxin.
Conclusions and Significance: Thus, the results shown here provide the novel evidence that martentoxin could increase the
two Ca
2+-hypersensitive BK channel subtypes activities in a new manner and indicate that b subunit of these BK channels
plays a vital role in this enhancement by martentoxin.
Citation: Tao J, Shi J, Yan L, Chen Y, Duan YH, et al. (2011) Enhancement Effects of Martentoxin on Glioma BK Channel and BK Channel (a+b1) Subtypes. PLoS
ONE 6(3): e15896. doi:10.1371/journal.pone.0015896
Editor: Karl-Wilhelm Koch, University of Oldenburg, Germany
Received August 11, 2010; Accepted November 30, 2010; Published March 18, 2011
Copyright:  2011 Tao et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by grants from the National Basic Research Program of China (grant 2010CB529806), the National Nature Sciences Foundation
of China (grant 30772554), and the Leading Academic Discipline Project of Shanghai Municipal Education Commission "Molecular Physiology," National
Laboratory of Biomacromolecules (grant O5SY021097), Institute of Biophysics, Chinese Academy of Sciences and Innovation Fund for Graduate Student, Shanghai
University. The authors declare that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: yhji@staff.shu.edu.cn
. These authors contributed equally to this work.
Introduction
BK channels (voltage-dependent large-conductance Ca
2+-activat-
ed K
+ channels),also referred to as Maxi-K channels, resemble a
unique class of ion channels that couple intracellular chemical
signaling to electric signaling [1]. Though BK channels are activated
by both elevated cytosolic Ca
2+ and membrane depolarization, they
can open even in the absence of calcium [2]. Up to present, BK
channels have been demonstrated to regulate smooth muscle tone
[3,4,5,6,7], neuronal firing [8,9,10,11,12,13], endocrine cell secretion
[14,15], cell proliferation [16,17] and cell migration [18].
Functional BK channels are a tetramer of pore-forming a subunits
encoded by a single gene Slo [19,20] at least. Different from the close
homology of voltage-gated K
+ (Kv) channel, the a subunit of BK
channels possesses additional hydrophobic segments including a
transmembrane helix (S0) which places the N terminus on the
extracellular side of the plasma membrane[21] and a long cytosolic
C-terminal (S7-S10) where putative Ca
2+-binding sites reside[22].
Besides the coexpression of tissue-specific accessory b subunits,
alternative splicing of Slo gene can also lead to diverse BK channel
subtypes with various biophysical and pharmacological proper-
ties[23,24]. Among the BK channel subtypes, some including glioma
BK (gBK) and BK channel (a+b1) have been unraveled to share
higher Ca
2+ sensitivity [24,25,26]. gBK channel as a novel BK
channel isoform is almost exclusively expressed in human glioma cells
and the prominent expression is correlated positively with enhanced
malignancy grades[27,28]. The high Ca
2+ sensitivity of gBK channel
appears to be a necessity for the cross-talk between neuregulin-1
receptor erbB2 and the channel[29]. While, BK channel (a+b1)
expressed specifically in cardiovascular system is considered a key
player in balancing excessive vasoconstriction in virtue of its ability to
sense subtle Ca
2+ change evoked by depolarization[30]. Despite the
physiological or pathological importance of the higher Ca
2+ sensitive
BK channels has been clarified to some extent, the structural and
molecular mechanism underlying the Ca
2+ hypersensitivity of the
channels still remains unknown.
As is known to all, neurotoxins are invaluable tools for
examining structural and functional characteristics of targeting-
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Karsch (BmK), can block BK channel in adrenal medulla
chromaffin cells and modulate the activities of neuronal BK
channel subtype (a+b4) with Ca
2+-dependent manner[31,32]. The
neuronal BK channel (a+b4) currents were reduced in the
presence of low cytoplasmic Ca
2+ concentration, but conversely
enlarged in the presence of high cytoplasmic Ca
2+ concentration.
Moreover, the interaction between martentoxin and the neuronal
BK channel (a+b4) was implicated for a novel drug-docking
model. Since gBK and BK channel (a+b1) possessed higher Ca
2+
sensitivity than the neuronal BK channel (a+b4) in the
physiological condition, it is very intriguing to investigate the
modulatory characteristics of martentoxin on these two BK
channel subtypes.
Materials and Methods
Cell culture and transfection
All experiments were performed on the glioma cell lines U251
(World Health Organization grade IV, glioblastoma multiforme)
and HEK 293T cell lines. U251 cells and HEK 293T cells were
obtained from Shanghai cell bank of Chinese Academy of Science.
The cells were both cultured in Dulbecco’s modified Eagle
medium (DMEM; Life Technologies, Grand Island, NY) supple-
mented with 10% heat –inactivated fetal bovine serum (FBS;
Gibco, Grand Island, NY). Culture dishes were incubated at 37uC
in a humidified atmosphere containing 5% CO2, and subcultured
approximately every 2,3 days. The plasmids containing hSloa
(U23767) and b1 (KCNMB4; U25138) are gifts from N.W. Davies
(University of Leicester) and J.D. Lippiat (Leeds university). One
day before transfection, HEK 293T cells were transferred to 24-
well plates. At 90% confluence, cells were transiently transfected
using Lipofectamine2000 (Invitrogen, USA) at a ratio of 2 mL
reagent with 1 mg total plasmid per well. Electrophysiological
experiments were performed at 1,2 days after transfection.
Electrophysiological recordings
Whole-cell voltage-clamp experiments were performed as
described previously [33], using an EPC-9 amplifier (HEKA
Eletronik, Germany) at room temperature (21uC –25uC). Patch
pipettes were fabricated from glass capillary tubes by PC-10 Puller
(Narishige, Japan) with the resistance of 2,3M V. Data
acquisition and stimulation protocols were controlled by a
Pentium III computer (Legend, Beijing, China) equipped with
Pulse/PusleFit 8.3 software (HEKA Eletronik, Germany). Capac-
itance transients were cancelled. Cells with a seal resistance (Rseal)
below 1 GV were omitted. Series resistance (Rs) was compensated
(75,80%) to minimize voltage errors, and cells with a uncom-
pensated series resistance (Rs) above 10 MV were omitted. Leak
subtraction was performed using P/6 protocol. Data were low-
passed at 10 kHz. The rate of solution exchange was studied using
solutions with different KCl concentrations and found to be about
95% complete within 20 s. For U251 cells, the holding potential
was 260 mV. Unless stated specially, all the recordings were done
with the pulse of +100 mV. For HEK 293T cells, the holding
potential was 280 mV. Unless stated specially, all the recordings
were done with the pulse of +80 mV.
Ca
2+ fluorescence measurements by Fura-2
The U251 cells were loaded with 12.5 mM fura-2 AM
(Molecular Probes, Dojindo Laboratories, Kumamoto, Japan) in
this prepared culture medium at 37uC for 1.5 h. The final
concentration of 15% Pluronic acid F-127 was,0.02% (wt/vol).
The HEK 293T cells were incubated with 5 mM fura-2 AM in
HEPES buffered solution for 30 min at 37uC.
The measurement of changes in cellular Ca
2+ concentration by
Fura-2 was performed as described previously[32,34]. Fluores-
cence images were acquired with an inverted microscope (IX-70,
Olympus Optical Co., Tokyo, Japan) equipped with a digital CCD
(charge-coupled device) camera (C4742-95-12NRB, Hamamatsu
Photonics K. K., Japan). A high-speed scanning polychromatic
light source (C7773, Hamamatsu Photonics K. K., Hamamatsu,
Japan) was used for alternating excitations at wavelengths of
340 nm and 380 nm. Data collection and analyses were
performed using a Ca
2+ imaging system (Aquacosmos Ver1.2,
Hamamatsu Photonics K. K., Japan). The sampling interval of
Fura-2 fluorescence measurements was 5 s.
Solutions and drugs
In the patch-clamp recordings, the standard bath solution for
U251 cells was consisted of the following (in mM): NaCl 150, KCl
5.6, MgCl2 1, CaCl2 2, glucose 10, and HEPES (N-(2-
hydroxyethyl) piperazine-N’- (2-ethanesulfonic acid)) acid 10(pH
7.3 with NaOH). Pipette solutions for U251 cells was composed of
the following (in mM): KCl 140, MgCl2 1, EGTA 5, HEPES acid
10(pH 7.2 with KOH). The standard bath solution for HEK 293T
cells was consisted of the following (in mM): NaCl 135, KCl 5,
MgCl2 1.2, CdCl2 2.5, HEPES 5, glucose 10 (pH 7.4 with
NaOH). Pipette solutions for HEK 293T cells was composed of
the following (in mM): NaCl 10, KCl 117, MgSO4 2, HEPES 10,
MgATP 2, EGTA 1 (pH 7.2 with KOH). The total Ca
2+ to be
added to give the desired free concentration was calculated using
the program Maxchelator (http://www.stanford.edu/%7Ecpat-
ton/maxc.html).
In the Ca
2+ imaging, the Krebs buffered solution for U251 cells
had a composition of (in mM): NaCl 130, K2HPO4 2.4, CaSO41,
MgSO4 1, D-glucose 10, and HEPES 10(pH 7.4 with NaOH).
The HEPES buffered solution for HEK 293T cells had a
composition of (in mM): NaCl 137, KCl 5.9, MgCl2 1,CaCl2
2.5, HEPES 10, glucose 15 (pH 7.4 with NaOH).
The toxin was dissolved in the bath solution, supplemented with
1 mg/mL bovine serum albumin (BSA) in order to prevent
adherence of the toxin to the vials and the perfusion apparatus.
Application of 1 mg/mL BSA alone did not alter BK channel
function. Unless otherwise stated, all reagents were purchased
from Sigma.
Cell Proliferation Assay
Cell proliferation assays were performed by using Cell
CountingKit-8 (Dojindo, Kumamoto, Japan). Cells were plated
in 96-well plates at 1610
4 cells per well and final volume of cell
culture medium in each well was 0.2 mL. The second day,
medium was removed, and cells were washed once with sterile
phosphate-buffered saline (PBS) and treated with serum-free
media as ‘‘control’’. The next day, cells were treated with various
concentrations of drugs or chemicals for 48 h. IbTx was added
directly to the wells at final concentrations of 100 nM, and the
medium was changed daily throughout the course of the
experiment. For dose-response experiments, cells were incubated
in serum-free media containing 0, 20, 100, 500, and 1000 nM
martentoxin. For time course experiments, cell numbers were
determined daily. At the indicated time points, the cell numbers in
the wells were measured by the absorbance (450 nm) of reduced
WST-8 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-dis-
ulfophenyl)-2H-tetrazolium, monosodium salt). The assay was
conducted in five replicate wells for each sample concentration
and controls. Three parallel experiments were performed. All
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different drug conditions were performed on serum-free culture.
The cell viability of samples at each concentration of the drugs or
chemicals was calculated by dividing the optical density of samples
with that of control.
Data analysis
Data were analyzed by PulseFit 8.5 (HEKA Eletronik,
Germany) and Origin 7.5 (Northampton, Massachusetts, USA).
Results of data analysis were expressed as mean6S.E.M. and n
represents the number of the cells examined.
The Statistical significance was determined using the unpaired
Student’s t-Test or one-way ANOVA, and an asterisk denotes
P,0.05 unless otherwise stated. The degree of toxin effect was
calculated by expressing the remaining current after each drug
exposure as a fraction of the current magnitude of the patch prior
to the first drug exposure (i.e., fractional current remaining, If).
Dose-response curve for the percent enhancement of gBK or
BK channel (a+b1) currents was drawn according to the Hill
equation I= Im/(1+([toxin]/EC50)
n), where Im is maximum
enhanced percentage of BK currents, and [toxin] is the
concentration of martentoxin. EC50 (half-maximal effective
concentration) and n denote the toxin concentration of half-
maximal effect and the Hill coefficient, respectively.
gBK or BK channel (a+b1) currents was elicited by the step
pulses ranging from – 50 to +120 mV for 200 ms with the
increments of 10 mV (The holding potentials were held at –
60 mV for gBK and 280 mV for BK channel (a+b1), respective-
ly). For determining the voltage dependence of activation, the
conductance was calculated using the formula: G(V)= I(V)/(V–
ErK), where I(V) is the currents of gBK or BK channel (a+b1) at
the command voltage V, and ErK is the reversal potential. The
conductance were normalized to the maximal value and the
voltage dependence for activation of gBK and BK channel (a+b1)
fitted to a Boltzmann equation: f(x)=–1/(1+exp((x–V1/2)/k)) +1,
where V1/2 is the voltage at which half-maximal activation occurs,
and k describes the slope of the fit.
Results
Abundance of gBK expression in U251 glioma cells
The outward currents of U251 glioma cells evoked by the pulse
of 100 mV were almost completely inhibited by iberiotoxin, a
specific BK channel inhibitor. The residual currents in the
presence of 100 nM or 500 nM iberiotoxin were 0.1460.02
(n=6) or 0.1460.01 (n=6) of the control (Fig. 1A and 1B). The
abundance of gBK expression in the U251 glioma cells is
responsible for ,90% of the outward currents. The remaining
currents could be almost completely inhibited by 200 mM NPPB
(5-nitro-2-(3-phenylpropylamino) benzoic acid) (If: 0.02160.004
compared to 0.1460.01, p,0.001, n=6) (Fig. S1). Therefore, the
currents are suggested to be NPPB sensitive Cl
2 channels [28,35].
Figure 1. Characterization of gBK expression in U251 cells. (A) Representative whole cell current traces from U251 cells before and after the
application of iberiotoxin (IbTx) 100 nM and 500 nM. The holding voltage was 260 mV and the currents were elicited by a pulse of +100 mV with
150 nM free Ca
2+ in the pipette solution. (B) Statistics analysis of iberiotoxin-sensitive gBK channels in U251 cells as describe in A. Plot of the fraction
of unblocked current (If, see ‘‘Data analysis’’) versus the iberiotoxin concentration. Each point presents data from 6 cells. (n=6). *** p,0.001.
doi:10.1371/journal.pone.0015896.g001
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2 currents to
martentoxin
As shown in Fig. 1, gBK currents of U251 glioma cells were
completely inhibited by 100 nM iberiotoxin. After the pre-
treatment of the cells with iberiotoxin (100 nM), the mixture of
100 nM martentoxin and 100 nM iberiotoxin was simultaneously
administrated, the remaining outward currents by 100 nM
iberiotoxin alone were not significantly different (If: 0.1460.02
compared to 0.1760.02, p.0.05,n=4) (Fig. 2). Obviously, the
remaining NPPB sensitive Cl
2 currents were insensitive to
martentoxin.
Dose-dependent modulation of martentoxin on gBK
channels
In the case that the free Ca
2+ concentration in the pipette
solution was controlled to 150 nM, the gBK channel currents
could be enhanced by martentoxin in dose-dependent manner.
The EC50 of martentoxin on gBK channels was assessed to be
46.767.82 nM with a Hill coefficient of n=1.4060.26 according
to the dose-response curve fitting (n=3–8) (Fig. 3A and 3B).
Free Ca
2+ concentration in the U251 glioma cells was normally
about hundreds nM level and the proliferation of human
malignant glioma cells including U251 cells could be decreased
by iberiotoxin, a specific gBK channel inhibitor[17]. Unexpect-
edly, the cell number was significantly increased 48 h after the
application of martentoxin under the serum-free cell culture
condition. Following the elevated concentration of martentoxin,
the cell growth was accelerated likewise. The cell number was
increased to 1.0260.01 (n=10), 1.3960.05 (n=10), 1.7560.05
(n=10) and 2.5160.08 (n=10) compared with the drug-free
controls after the administration of martentoxin 20 nM, 100 nM,
500 nM and 1000 nM, respectively (Fig. 3C and D). On the
contrary, the cell number was decreased at 48 h after the
application of 100 nM IbTx under the serum-free cell culture
condition. Furthermore, the cell number with the treatment of the
mixture of 500 nM martentoxin and 100 nM iberiotoxin was not
significantly different from that with the treatment of 100 nM
iberiotoxin alone (If: 0.8760.01 compared to 0.8660.01, p.0.05,
n=15) (Fig. 3C and 3D). This result showed that IbTx could
completely abolish the cell proliferation induced by martentoxin,
which strongly implied that gBK channel was the unique target of
martentoxin.
Ca
2+-dependent and voltage-independent modulation of
martentoxin on gBK channels
In the case that U-251 cells were pre-treated with 200 nM
thapsigargin, an irreversible inhibitor of the sarcoplasmic reticu-
lum Ca
2+-ATPase pump for 30 min at 37uC in order to deplete
intracellular Ca
2+ stores before performing whole cell patch
recordings of gBK currents[36]. The pipette solution contained
10 mM EGTA but without Ca
2+, the gBK channels were blocked
by 100 nM martentoxin (If:0.7060.09, n=4). When the free Ca
2+
concentration was elevated to 150 nM or 28 mM, the activities of
gBK channels were conversely enhanced by 100 nM martentoxin.
But the enhancement ratios of gBK channel activities were not
significantly different (If: 1.3860.03,n=8; 1.4660.02, n=4,
p.0.05). (see Fig. 4A and 4B).
Ca
2+ imaging showed that the cytoplasmic Ca
2+ concentration
in glioma cells could not be oscillated by 100 nM or 500 nM
martentoxin. Contrary to this, an obvious Ca
2+ rise could be
evoked by the solution with 100 mM caffeine (Fig. S2A),
indicating that the cytoplasmic Ca
2+ concentration after the
establishment of the whole-cell mode was consistent with that in
the pipette solution and remained almost unchanged during the
recording. Consequently, the enhancement of gBK channel
activity was induced by martentoxin directly.
W h e nt h ef r e eC a
2+ concentration in the pipette solution
was remained at 150 nM, the gBK currents were elicited by
the step pulses ranging from – 50 to +120 mV for 200 ms
with the increments of 10 mV. Thus, the toxin effects on the
v o l t a g ed e p e n d e n c eo fs t e a d y - s t a t ea c t i v a t i o nw e r ea n a l y z e d
as described in ‘‘Data analysis’’. By perfusion with 100 nM
martentoxin, the activation curve of gBK channels as well
as the half-maximal voltage (V1/2) of activation was not signi-
ficantly shifted with the application of 100 nM martentoxin
(99.562.94 compared to 96.362.64,n=5, p.0.05) (Fig. 4D and
Table 1).
Dose-dependent and voltage-independent modulation
of martentoxin on BK channel (a+b1) expressed in
HEK293T cells
In the case that free Ca
2+ concentration in the pipette solution
remained at 700 nM, the currents of BK channel (a+b1) were
increased by martentoxin in the dose-dependent manner (Fig. 5A
and 5B). The EC50 of martentoxin on BK channel (a+b1) was
assessed to be 495626.7 nM with a Hill coefficient of
Figure 2. Insensitivity of the remaining iberiotoxin-insensitive outward currents to martentoxin in U251 cells. (A) Representative
whole cell current traces from U251 cells before and after the single application of iberiotoxin 100 nM, and simultaneous application of
iberiotoxin(IbTx) 100 nM and martentoxin (MarTx) 100 nM. The holding voltage was 260 mV and the currents were elicited by a pulse of +100 mV
(Fig. 1A). (B) Statistics analysis of unblocked current (If) after iberiotoxin 100 nM (n=4) and the mixture of two toxins (n=4). p.0.05.
doi:10.1371/journal.pone.0015896.g002
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U251 cells. The holding voltage was 260 mV and the currents were elicited by a pulse of +100 mV. Martentoxin (100 nM) could obviously enhanced
the outward currents. (B) The dose-response curve of martentoxin enhancing BK currents was fitted by the Hill equation (see ‘‘Data analysis’’). The
EC50 value is 46.767.82 nM, and the Hill coefficient is n=1.4060.26 (n=3–8). (C) Images of cells after 2 days under serum-free conditions without
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5). In addition, the effects of martentoxin on steady-state activation
of a+b1 subtype was studied by the same experimental voltage
protocol and the same data analysis as gBK channels (see ‘‘Data
analysis’’). A similar effect could be observed in the presence of
1 mM martentoxin. The activation curve of a+b1 BK channels
toxin (left),with martentoxin (middle), with IbTx or with the mixture of IbTx and martentoxin (right). (D) Relative cell number was measured 2 days
after the treatment of variant concentrations of martentoxin (n=10–15). *** p,0.001.
doi:10.1371/journal.pone.0015896.g003
Figure 4. Ca
2+-dependent and voltage-independent modulation of martentoxin on gBK channels. (A) Representative whole cell current
traces from U251 cells before and after the application of martentoxin 100 nM. The holding voltage was 260 mV and the currents were elicited by a
pulse of +100 mV with 0, 150 nM or 28 mM free Ca
2+ in the pipette solution. (B) Statistics analysis of modulation of gBK channels by martentoxin
100 nM in the presence of 0 (n=4), 150 nM (n=8), 28 mM (n=3) free Ca
2+ in the pipette solution, respectively. *** p,0.001. The enhancive ratios of
martentoxin on the gBK currents were not significantly different between 150 nM or 28 mM free Ca
2+ in the pipette solution (n =3, p.0.05). (C)
Representative whole cell current traces from U251 cells before (left) and after (right) the application of martentoxin 100 nM. The holding voltage was
260 mV and the currents was elicited by the step pulses ranging from – 50 to +120 mV for 200 ms with the increments of 10 mV. (D) The plots of the
normalized conductance as a function of command potential in the absence or presence of martentoxin, data points were fitted using the Boltzmann
function (‘‘see Data analysis’’). The voltage-dependent activation curve was not significantly shifted in the presence of martentoxin (n=5).
doi:10.1371/journal.pone.0015896.g004
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insignificantly moved (65.561.68 compared to 68.563.03, n=8,
p.0.05) (Fig. 5D and Table 1).
Ca
2+-dependent modulation of martentoxin on BK
channel (a+b1) expressed in HEK293T cells
In the case that HEK293T cells transfected with BK channel
(a+b1) were also pre-treated with 200 nM thapsigargin for 30 min
at 37uC. When Ca
2+ was fully excluded from the pipette solution,
the currents of BK channel (a+b1) evoked by +80 mV pulse could
not be modulated by martentoxin even at 1 mM (Fig. 6A).
However, when free Ca
2+ in the pipette solution was remained at
700 nM or 25 mM, the currents of BK channel (a+b1) were
enhanced by martentoxin 1 mM (Fig. 6A). Similar to the
modulation of martentoxin to gBK channel, the enhancive ratios
of martentoxin on the currents of BK channel (a+b1) were not
significantly different those at 700 nM or 25 mM free Ca
2+ in the
pipette solution (If: 1.2560.04,n=4 compared to 1.3060.02,
n=4; p.0.05) as shown in Fig. 6B. Nevertheless, the least time
from the control current to the peak current after the application
of martentoxin was distinguishing between 700 nM and 25 mM
free Ca
2+ in the pipette solution. The shortest time was 18566.4 s
(n=6) at 700 nM free Ca
2+, but shortened to 79.066.7 s (n=6) at
25 mM free Ca
2+ (Fig. 6C).
Table 1. The voltage independence of activation of gBK and
BK channel (a+b1) subtypes in the absence and presence of
martentoxin.
V1/2 (mV) k (mV) n
gBK
control 99.5062.94 12.0161.66 5
100 nM MarTx 96.3362.64, P.0.05 12.2261.60, P.0.05 5
BK (a+b1)
control 65.5661.68 24.3161.39 8
1 mM MarTx 68.5263.03, P.0.05 28.2962.39, P.0.05 8
The groups of control and MarTx have no significantly difference, at the level of
0.05, tested by one-way ANOVA.
doi:10.1371/journal.pone.0015896.t001
Figure 5. Dose-dependent and voltage-independent modulation of martentoxin on BK channels (a+b1) expressed in HEK293T cells.
(A) Representative whole cell current traces from HEK 293T cells expressing BK channels (a+b1) before and after the application of martentoxin 1 mM.
The holding voltage was 280 mV and the currents were elicited by a pulse of +80 mV with 700 nM free Ca
2+ in the pipette solution. (B) The dose-
response curve of martentoxin enhancing BK currents was fitted by the Hill equation (see ‘‘Data analysis’’). The EC50 value is 495626.7 nM, and the
Hill coefficient is n=1.3960.09 (n=3–5). (C) Representative whole cell current traces from HEK 293T cells expressing BK channels (a+b1) before (left)
and after (right) the application of martentoxin 1 mM. The holding voltage was 280 mV and the currents were elicited by the step pulses ranging
from – 50 to +120 mV for 200 ms with the increments of 10 mV. (D) The plots of the normalized conductance fit well with Boltzmann function (‘‘see
Data analysis’’). The voltage-dependent activation curve was insignificantly shifted in the presence of martentoxin (n=8).
doi:10.1371/journal.pone.0015896.g005
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2+ imaging showed that the cytoplasmic Ca
2+ concentration
in HEK 293T cells could not be oscillated by 1 mM martentoxin,
suggesting that the cytoplasmic Ca
2+ concentration remained
almost unchanged during the recording (Fig. S2B). Therefore, it is
clear that the martentoxin could modulate BK channel (a+b1)
directly, without elevating cytosolic Ca
2+.
Iberiotoxin abolished the enhancement of martentoxin
on the activity of BK channel (a+b1)
The currents of BK channel (a+b1) could be markedly inhibited
by iberiotoxin, a pore blocker of BK channels, or the mixture of
iberiotoxin and martentoxin. If was 0.4760.03 (n=5) at 400 nM
iberiotoxin. Similarly, If was 0.5360.06 (n=4) with the mixture of
1 mM martentoxin and 400 nM iberiotoxin (Fig. 7).
Discussion
The modulatory characteristics of gBK channel and BK
channel (a+b1), two Ca
2+-hypersensitive BK channel subtypes,
by martentoxin were investigated in the present study. The
activities of both BK channel (a+b1) and gBK channel could be
enhanced by martentoxin, depending on the presence of
cytoplasmic free Ca
2+.
Selectivity of martentoxin on BK channel subtypes
BK channels consist of two distinct subunits, the pore-forming a
subunit (slo) and the b regulatory subunit [37]. Alternative splicing
of the slo mRNA [27] as well as tissue-specific b subunits are found
to give rise to diverse subtypes [38]. However, other specific
Figure 6. Ca
2+-dependent modulation of martentoxin on BK channels (a+b1) expressed in HEK293T cells. (A) Representative whole cell
current traces from HEK 293Tcells expressingBK channels (a+b1)before andafter the application ofmartentoxin1 mM.The holding voltage was 280 mV
and the currents were elicited by a pulse of +80 mV with 0, 700 nM or 25 mMf r e eC a
2+ in the pipette solution. (B) Statistics analysis of modulation of BK
channels (a+b1) by martentoxin 1 mM in the presence of 700 nM or 25 mMf r e eC a
2+ in the pipette solution (n=6). *** p,0.001. The enhancive ratios of
martentoxin on the currents of a+b1 subtype were not significantly different between 700 nM or 25 mM free Ca
2+ in the pipette solution (n=4; p.0.05)
(C) Time course for the up-modulation of BK channels (a+b1) by martentoxin 1 mM in the presence of 700 nM or 25 mMf r e eC a
2+ in the pipette solution
(left). Statistics analysis (n=6) of the shortest time between the control current and the peak currents induced by martentoxin 1 mM( r i g h t ) .p .0.05.
doi:10.1371/journal.pone.0015896.g006
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discriminate these subtypes.
Our initial study showed that 100 nM martentoxin could potently
block BK channel currents in adrenal medulla chromaffin cells in
which b2 subunit may be coexpressed with a subunit [31].
Subsequently, it was shown that the iberiotoxin-insensitive neuronal
BKchannels(a+b4) could bestronglyblocked bymartentoxin,while
the iberiotoxin-sensitive BK channel consisting of only a subunit was
almost insensitive to martentoxin [34]. In the present study, it was
found that the activities of gBK and BK channel (a+b1) subtypes
were both enhanced by martentoxin. Furthermore, martentoxin
displayed a higher preference with gBK channel over BK channel
(a+b1) by about 10 folds (Fig. 3B and 5B). This subtype-selectivity of
martentoxin may possibly attribute to the different modulatory
effects of diverse b subunits or alternative splicing of a subunit of BK
channels. Over all, martentoxin could be utilized not only as a
specific blocker for neuronal BK channel subtype but also as a
modulator for discriminating most BK channel subtypes.
Ca
2+-dependent modulation of martentoxin on BK
channel subtypes
Ca
2+ sensor of the BK channel formed by only a subunits is
composed of multiple Ca
2+ binding sites distributing in the
cytoplasmic C-terminal region. These sites bind Ca
2+ with
different affinity[39]. Since the Ca
2+ or voltage sensor for BK
channel activation can act relatively independently to each other
[40,41], it is thus implied that the activation conformation of BK
channel induced by variant cytoplasmic Ca
2+ concentrations may
be different.
Our previous study showed that the neuronal BK channel
(a+b4) currents could be reduced by martentoxin in the presence
of low cytoplasmic Ca
2+ concentration, but conversely increased in
the presence of high cytoplasmic Ca
2+ concentration[34]. That is
corresponding to the notion that b4 subunit reduces BK channel
openings at low cytoplasmic Ca
2+ while increases channel
openings at high cytoplasmic Ca
2+[42]. It is thus indicated that
the pharmacological effects of martentoxin would be reversed
subject to the change of conformation of BK channel.
In this study, it was found that the activities of gBK and BK
channel (a+b1) subtypes were both up-modulated by martentoxin
only in the presence of cytoplasmic free Ca
2+. When Ca
2+ was
completely removed from the pipette solution, the activity of gBK
channel was conversely inhibited, but the activity of BK channel
(a+b1) was unaltered by martentoxin. It thus clearly suggested
whether the presence or absence of cytoplasmic Ca
2+ was also
crucial to the effects of martentoxin on such BK channel subtypes.
Figure 7. The enhancement effect of martentoxin on BK channels (a+b1) could be fully abolished by IbTx. (A) Representative whole cell
current traces from HEK 293T cells expressing BK channels (a+b1) before and after the application of IbTx 400 nM (left) or the mixture of IbTx 400 nM
and martentoxin 1 mM (right). The holding voltage was 280 mV and the currents were elicited by a pulse of +80 mV in the presence of 700 nM free
Ca
2+ in the pipette solution (Fig. 5A). (B) Statistics analysis of pharmacological modulation of gBK channels by IbTx 400 nM (n=5) or the mixture of
IbTx 400 nM and martentoxin 1 mM. (n=4) p.0.05.
doi:10.1371/journal.pone.0015896.g007
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unknown how martentoxin modulates other BK channel subtypes.
But the present results implied that the pharmacological effects of
martentoxin on BK channel subtypes depended partly on the Ca
2+
binding sites of BK channels directly or indirectly. Since there is a
close coupling between Ca
2+ binding site and other regions
especially b subunit of BK channel, martentoxin may bind with
these specific regions correlated closely with Ca
2+ binding sites
because as a peptide, martentoxin could not reach the cytoplasm
of the cell.
Up-modulatory mechanism of martentoxin on activity of
gBK and BK channel (a+b1) subtypes
gBK channels are abundant in human glioma cells and
contribute to ,90% of the outward currents. This study found
that, contrary to iberiotoxin[17], martentoxin could accelerate the
proliferation of glioma cells (Fig. 3C and D). It strongly suggested
that gBK channel was the direct target of martentoxin. Moreover,
the block potency on the outward currents with the simultaneous
application of martentoxin and iberiotoxin was not significantly
different from that by iberiotoxin alone. The result indicated that i)
the remaining NPPB sensitive Cl
2 channel was not recognized by
martentoxin, ii) the receptor site of gBK channel associating with
martentoxin and iberiotoxin was not overlapping. As the pore
region was usually regarded as the target of iberiotoxin, the
docking sites of gBK channel for martentoxin might be far from
the pore region. The voltage-dependence of gBK and BK channel
(a+b1) was not shifted by martentoxin (Fig. 4D and 5D), which
rules out the possibility that martentoxin interacts directly with the
voltage sensor. Furthemore, accumulated data supported that b
subunit might affect the pharmacological or Ca
2+ sensitive
characteristics of gBK channel[25,27]. It allow us to speculate
that b subunit of gBK channel might underlie the receptor sites for
martentoxin. Similarly, BK channel consisted of a subunit alone
was insensitive to martentoxin even at the concentration of toxin
elevated to 1 mM (Fig. S3). Moreover, the enhancement of
martentoxin on the activity of BK channel (a+b1) could be
completely abolished by IbTx (Fig. 7). What’s more, our recent
preliminary work showed that the extracellular loop of b1 subunit
plays a crucial role in interacting with martentoxin (unpublished
data Tao et al.). Hence, these results strongly implied that the
enhancement of martentoxin on these BK channel subtypes may
come from its binding directly to b1 subunit.
Martentoxin, a valuable tool to BK channel-related
diseases research and drug-design
Malignant gliomas are the most common primary intracra-
nial tumors with high mortality [43]. Prominent expression of
BK channel in human glioma cells is correlated positively with
enhanced malignancy grades [27,28]. Our results showed that
martentoxin displayed a high sensitivity on glioma BK channels
( F i g .3 B ) .I tw a ss t r o n g l yi m p l i e d that martentoxin, a molecular
probe of gBK channel, could be used for testing human
gliomas. Moreover, proliferation of U251 cells could be
obviously enhanced by martentoxin under the serum-free
condition (Fig. 3C and 3D). The underlying mechanism of
gBK channels affecting on the cell cycle remains unknown.
Also, it is still unclear whether martentoxin could protect
normal glia cells under the serum-free condition. Such
investigations with martentoxin may clarify the mechanism
how the gBK channel produce or relate to the malignant
proliferation.
On the other hand, BK channel (a+b1) activated by local Ca
2+
release could regulate the membrane potential of arterial smooth
muscle cells and protect against hypertension [6]. Activation of BK
(a+b1) channels by pharmacologic tools may be an effective
treatment for hypertension disorders with increased smooth
muscle tone. This study showed that the currents of BK channel
(a+b1) could be strongly increased by martentoxin (Fig. 5A and
5B). It may allow us to speculate that martentoxin could be utilized
as a scaffold for designing novel modifiers to enhance channel
activity.
Supporting Information
Figure S1 Sensitivity of the remaining iberiotoxin-
insensitive outward currents to NPPB in U251 cells. (A)
Representative whole cell current traces from U251 cells before
and after the single application of iberiotoxin (IbTx) 100 nM, and
simultaneous application of iberiotoxin 100 nM and NPPB
200 mM. The holding voltage was 260 mV and the currents
were elicited by a pulse of +100 mV (see Fig. 1A). (B) Statistics
analysis of unblocked current (If) after iberiotoxin 100 nM (n=6)
and the mixture of iberiotoxin and NPPB (n=6). P,0.001.
(TIF)
Figure S2 Effects of martentoxin on cytoplasmic Ca
2+.
(A) Effects of martentoxin on cytoplasmic Ca
2+ of U251 cells. After
the application of martentoxin 100 nM or 500 nM, the cytoplas-
mic Ca
2+ concentration was unchanged. (B)Effects of martentoxin
on cytoplasmic Ca
2+ of HEK 293T cells. After the application of




Figure S3 Slight effect of martentoxin on BK channels
(hsloa alone). (A) Representative current traces are shown. The
channels were activated by +80 mV with a 280 mV holding
potential (see Fig. 5A). The free Ca
2+ concentration in the pipette
solution was 700 nM. The currents were hardly altered by 1 mM
of martentoxin. (B) The time course curve confirmed the lack of
sensitivity of this type (a alone) of BK channels to martentoxin.
(TIF)
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